| Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK KB Pouwels, E Pritchard, PC Matthews, N Stoesser, DW Eyre, KD Vihta, ... Nature medicine 27 (12), 2127-2135, 2021 | 641 | 2021 |
| Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom E Pritchard, PC Matthews, N Stoesser, DW Eyre, O Gethings, KD Vihta, ... Nature medicine 27 (8), 1370-1378, 2021 | 334 | 2021 |
| Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey KB Pouwels, T House, E Pritchard, JV Robotham, PJ Birrell, A Gelman, ... The Lancet Public Health 6 (1), e30-e38, 2021 | 191 | 2021 |
| Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998–2016: a study of electronic … KD Vihta, N Stoesser, MJ Llewelyn, TP Quan, T Davies, NJ Fawcett, ... The Lancet Infectious Diseases 18 (10), 1138-1149, 2018 | 162 | 2018 |
| Omicron-associated changes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) symptoms in the United Kingdom KD Vihta, KB Pouwels, TEA Peto, E Pritchard, T House, R Studley, ... Clinical Infectious Diseases 76 (3), e133-e141, 2023 | 121 | 2023 |
| Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time AS Walker, E Pritchard, T House, JV Robotham, PJ Birrell, I Bell, JI Bell, ... Elife 10, e64683, 2021 | 102 | 2021 |
| Tracking the emergence of SARS-CoV-2 alpha variant in the United Kingdom AS Walker, KD Vihta, O Gethings, E Pritchard, J Jones, T House, I Bell, ... New England Journal of Medicine 385 (27), 2582-2585, 2021 | 78 | 2021 |
| High Rates of Human Fecal Carriage of mcr-1–Positive Multidrug-Resistant Enterobacteriaceae Emerge in China in Association With Successful Plasmid Families LL Zhong, HTT Phan, C Shen, KD Vihta, AE Sheppard, X Huang, KJ Zeng, ... Clinical Infectious Diseases 66 (5), 676-685, 2018 | 71 | 2018 |
| Increased infections, but not viral burden, with a new SARS-CoV-2 variant AS Walker, KD Vihta, O Gethings, E Pritchard, J Jones, T House, I Bell, ... MedRxiv, 2021.01. 13.21249721, 2021 | 68 | 2021 |
| Impact of vaccination on SARS-CoV-2 cases in the community: a population-based study using the UK’s COVID-19 Infection Survey E Pritchard, PC Matthews, N Stoesser, DW Eyre, O Gethings, KD Vihta, ... medRxiv, 2021.04. 22.21255913, 2021 | 59 | 2021 |
| Ten-year longitudinal molecular epidemiology study of Escherichia coli and Klebsiella species bloodstream infections in Oxfordshire, UK S Lipworth, KD Vihta, K Chau, L Barker, S George, J Kavanagh, T Davies, ... Genome Medicine 13, 1-13, 2021 | 49 | 2021 |
| Systematic review of wastewater surveillance of antimicrobial resistance in human populations KK Chau, L Barker, EP Budgell, KD Vihta, N Sims, B Kasprzyk-Hordern, ... Environment International 162, 107171, 2022 | 47 | 2022 |
| Symptoms and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positivity in the general population in the United Kingdom KD Vihta, KB Pouwels, TEA Peto, E Pritchard, DW Eyre, T House, ... Clinical Infectious Diseases 75 (1), e329-e337, 2022 | 38 | 2022 |
| Viral load in community SARS-CoV-2 cases varies widely and temporally AS Walker, E Pritchard, T House, JV Robotham, PJ Birrell, I Bell, JI Bell, ... MedRxiv, 2020.10. 25.20219048, 2020 | 27 | 2020 |
| Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections S Lipworth, KD Vihta, KK Chau, J Kavanagh, T Davies, S George, ... Clinical Infectious Diseases 73 (12), 2276-2282, 2021 | 22 | 2021 |
| Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillance E Pritchard, J Jones, KD Vihta, N Stoesser, PC Matthews, DW Eyre, ... The Lancet Regional Health–Europe 13, 2022 | 18 | 2022 |
| Impact of vaccination on SARS-CoV-2 cases in the community: a population-based study using the UK’s COVID-19 Infection Survey. medRxiv E Pritchard, PC Matthews, N Stoesser, DW Eyre, O Gethings, KD Vihta Published online April 2021 (2021.04), 22.21255913, 2021 | 12 | 2021 |
| Increased infections, but not viral burden, with a new SARS-CoV-2 variant. medRxiv 2021 AS Walker, KD Vihta, O Gethings, E Pritchard, J Jones, T House, I Bell, ... Google Scholar, 0 | 8 | |
| Molecular epidemiology and antimicrobial resistance phenotype of paediatric bloodstream infections caused by Gram-negative bacteria S Lipworth, KD Vihta, T Davies, S Wright, M Tabirao, K Chau, A Vaughan, ... Communications Medicine 2 (1), 101, 2022 | 6 | 2022 |
| Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. medRxiv. 2021: 2021.08. 18.21262237 v1 KB Pouwels, E Pritchard, P Matthews, NB Stoesser, DW Eyre, KD Vihta Epub Aug 24, 0 | 6 | |
